Examining Depression in Parkinson's Disease in Sociocultural Contexts: Moving from Stigma to Care
Keywords:
Anxiety, Depression, Parkinson's disease, stress, pakistanAbstract
OBJECTIVE: To estimate the prevalence of depression and to explore socio-demographic and clinical risk factors among tertiary-care patients with Parkinson's disease (PD) in Pakistan.
METHODOLOGY: This cross-sectional analytical design study was conducted in the outpatient department (OPD) of a tertiary care medical facility (CMH), Lahore, from March to May 2023. Ninety-four consecutive idiopathic PD patients were recruited for the cross-sectional analytical study from CMH Lahore. The study utilized a self-report questionnaire and the Harvard Department of Psychiatry/National Depression Screening Day Scale (HANDS) to gather data on patients' age, sex, marital status, employment status, and disease duration. In the study, adult patients with idiopathic Parkinson's Disease without any severe medical conditions were included.
RESULTS: The patients were 53 males and 41 females. The prevalence of depression in the study population was 39.36% (N 94). Most of the patients were diagnosed in the age group 51-60 years, and they were found to be more depressed than the younger patients. The most often reported symptoms of depression among individuals who were more depressed were low energy, trouble focusing or making decisions, feeling hopeless, feeling blue, and having trouble sleeping. All analyses were done on SPSS version 26.0 for Windows.
CONCLUSION: In Parkinson's disease (PD), depression symptoms are prevalent, particularly in individuals with more severe cognitive impairment who are more likely to have or aggravate depression. Thus, it is equally important to identify and treat the disease along with any associated depression.
References
de Hemptinne C, Chen W, Racine CA. Prefrontal Physiomarkers of Anxiety and Depression in Parkinson's Disease. Front Neurosci. 2021; 15. doi: 10.3389/fnins.2021.748165.
Rajagopalan M, Ranganathan LN, Valarmathi S, Govindarajulu S, Seshayyan S. Depression and Quality of Life of Parkinson's disease patients – A hospital-based cross-sectional study. Indian J Med Sci. 2022; 74: 57-61. doi: 10.25259/ijms_77_2021.
Tran AA, De Smet M, Grant GD, Khoo TK, Pountney DL. Investigating the Convergent Mechanisms between Major Depressive Disorder and Parkinson's Disease. Complex Psychiatry. 2021; 6(3-4): 47-61. doi: 10.1159/000512657.
Stocchi F, Angelo Antonini, Barone P. Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management. Neurological Sciences. 2023; 44(9): 3123-3131. doi: 10.1007/s10072-023-06740-w.
Assariparambil AR, Noronha JA, Kamath A. Depression among older adults: a systematic review of South Asian countries. Psychogeriatrics. 2021; 21(2): 201-219. doi: 10.1111/psyg.12644.
Stocchi F, Angelo Antonini, Barone P. Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management. Neurologic Sci. 2023; 44(9): 3123-3131. doi: 10.1007/s10072-023-06740-w.
Bucks RS, Cruise KE, Skinner TC, Loftus AM, Barker RA, Thomas MG. Coping processes and health-related quality of life in Parkinson's disease. Int J Geriatr Psychiatry. 2011; 26(3): 247-255. doi: 10.1002/gps.2520.
Farabaugh AH. Pattern of Depressive Symptoms in Parkinson's Disease. Psychosomatics . 2009; 50(5): 448-454.
Sujith P, Arjunan P, Iype T, Natarajan V. Depression in Patients With Parkinson's Disease: A Hospital-Based Cross-Sectional Study. Cureus. Published online October 17, 2023. doi: 10.7759/cureus.47214.
Chikatimalla R, Dasaradhan T, Koneti J, Cherukuri SP, Kalluru R, Gadde S. Depression in Parkinson's Disease: A Narrative Review. Cureus. Published online August 7, 2022. doi: 10.7759/cureus.27750.
Sujith P, Arjunan P, Iype T, Natarajan V. Depression in Patients With Parkinson's Disease: A Hospital-Based Cross-Sectional Study. Cureus. Published online October 17, 2023. doi: 10.7759/cureus.47214.
Prange S, Klinger H, Laurencin C, Danaila T, Thobois S. Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment. Drugs Aging. 2022; 39(6): 417-439. doi: 10.1007/s40266-022-00942-1.
Agüera-Ortiz L, García-Ramos R, Grandas Pérez FJ. Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics. Parkinsons Dis. 2021; 2021. doi: 10.1155/2021/6621991.
Shiba M, Bower JH, Maraganore DM. Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study. Movement Disorders. 2000; 15(4): 669-677.
Li N, Zhang D. Analysis of Clinical Features and Influencing Factors of Depression and Cognitive Dysfunction in Parkinson's Patients. J Clin Nurs Res. 2023; 7(5). http://ojs.bbwpublisher.com/index.php/JCNR.
Zhang T, Yang R, Pan J, Huang S. Parkinson's disease-related depression and anxiety: A 22-year bibliometric analysis (2000-2022). Neuropsychiatr Dis Treat. 2023; 19: 1477-1489. doi: 10.2147/NDT.S403002.
Stocchi F, Angelo Antonini, Barone P. Exploring depression in Parkinson's disease: an Italian Delphi Consensus on phenomenology, diagnosis, and management. Neurologic Sci. 2023; 44(9): 3123-3131. doi: 10.1007/s10072-023-06740-w.
Váradi C. Clinical features of Parkinson's disease: The evolution of critical symptoms. Biology (Basel). 2020; 9(5). doi: 10.3390/biology9050103.
Shehata GA, Farweez HM, Ali AM. Impact of Parkinsonism comorbid depression on cognitive functions. Egyptian J Neurology Psychiatry Neurosurgery. 2024; 60(1). doi: 10.1186/s41983-024-00813-z.
Mammen JR, Speck RM, Stebbins GM. Mapping Relevance of Digital Measures to Meaningful Symptoms and Impacts in Early Parkinson's Disease. J Parkinsons Dis. 2023; 13(4): 589-607. doi: 10.3233/JPD-225122.
Lemke MR. Depressive symptoms in Parkinson's disease. Eur J Neurol. 2008; 15(SUPPL. 1): 21-25. doi: 10.1111/j.1468-1331.2008.02058.x.
Patsi O, De Beaufort C, Kerschen P. A new PNPLA6 mutation presenting as Oliver McFarlane syndrome. J Neurol Sci. 2018; 392: 1-2. doi: 10.1016/j.jns.2018.06.016.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.
